John Mark Sutton
10Patents
3h-index
19Co-inventors
57Inventor score
Filing activity: Dec 4, 2000 → Aug 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7368532B2 | Constructs for delivery of therapeutic agents to neuronal cells | Chemistry; Metallurgy | 10 | Expired |
| US7470661B2 | Delivery of superoxide dismutase to neuronal cells | Chemistry; Metallurgy | 9 | Expired |
| US7303907B2 | Degradation and detection of TSE infectivity | Physics | 6 | Expired |
| US8017134B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 2 | Active |
| US8454976B2 | Recombinant toxin fragments | Emerging Cross-Sectional Technologies | 2 | Active |
| US11418044B1 | Method and apparatus for a battery charging station infrastructure including individual battery chargers | Electricity | 1 | Active |
| US8110391B2 | Degradation and detection of TSE infectivity | Physics | 0 | Active |
| US11942809B1 | Method and apparatus for a battery charging station infrastructure including individual battery chargers | Electricity | 0 | Active |
| US10640507B2 | PBD antibacterial agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US11746116B2 | Antibiotic resistance breakers | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.